Research News and Research

RSS

Merrimack and sanofi-aventis collaborate to develop and co-commercialize MM-121, a monoclonal antibody

Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today the signing of an exclusive worldwide licensing agreement for the development and co-commercialization of MM-121, a first-in-class, fully human monoclonal antibody designed to block signaling of the ErbB3 receptor. MM-121 is currently in Phase 1 clinical testing.

1 Oct 2009

Study aims to discover effective antibiotics to fight against hard-to-treat microbes

Scientists are reporting discovery of a much sought after crack in the armor of a common microbe that infects the stomachs of one-sixth of the world's population, causing stomach ulcers and other diseases. They identified a group of substances that block a key chemical pathway that the bacteria need for survival.

1 Oct 2009

NAACP endorses optometric vision therapy at its 100th Anniversary Convention

A routine visit to the eye doctor resulted in a national resolution that was passed by the NAACP at its 100th Anniversary Convention held in New York City, endorsing optometric vision therapy as a way to help some prisoners become productive members of society.

1 Oct 2009

Public lecture to highlight what causes cell division to go wrong and lead to cancer

University of Leicester research which substantially increases our understanding of what causes cell division to go wrong and lead to cancer will be highlighted in a public lecture at the University on Wednesday 14th October at 5.30-6.30pm.

1 Oct 2009

Studies show vitamin D plays an important role in preventing respiratory infections

Several studies and articles published this year show that vitamin D plays an important role in the prevention of respiratory infections such as the cold and flu.

1 Oct 2009

Cutting Edge Information hopes to see ill patients have speedier access to potential cures

The FDA has approved the first set of vaccines aimed at preventing H1N1 infection after an approval process of less than four months. Cutting Edge Information is currently analyzing the lessons learned that may emerge for both the Food and Drug Administration (FDA) and life science firms after this crisis experience.

1 Oct 2009

Raptor Pharmaceutical appoints Llew Keltner to its board of directors

Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.

1 Oct 2009

CCF to continue its million dollar ad campaign against NYC's PSA campaign

Today, the Center for Consumer Freedom (CCF) is running a full-page ad in the New York Times, continuing its million dollar ad campaign against the New York City Department of Health's hyperbolic "Don't drink yourself fat" PSA campaign. The Center will also continue to run ads in the New York Daily News and New York Post that ask New Yorkers, "What's Next?" and "Big Apple or Big Brother?"

1 Oct 2009

Cord Blood America to open cryogenic research and storage laboratory in Las Vegas

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it is opening its new Corporate headquarters and cryogenic research and storage laboratory in Las Vegas, as planned, the first week of October.

1 Oct 2009

Children and adolescents over five are at risk from malaria

Insecticide treated mosquito nets reduce the chances of developing life-threatening malaria in Africa, however recent research shows that older children are the least well protected by nets in the community. The research, published in the open access journal BMC Public Health, has found that parents and their young children were much more likely to have malaria nets than older children.

1 Oct 2009

Stem cell therapy aims to prevent permanent damage from heart attacks

All patients arriving at UCSF's Emergency Department with heart attack will continue to be treated with standard measures. Patients who meet the medical criteria for the trial will be able to elect to receive the stem cell therapy within seven days after their heart attack.

1 Oct 2009

Tata Interactive Systems collaborates with Bersin & Associates for TLF 2009

Tata Interactive Systems today announced that it has partnered with Bersin & Associates, the leading research and advisory firm focused on enterprise learning and talent management, on the agenda for its upcoming Tata Interactive Learning Forum, an annual, exclusive executive event scheduled for October 28 -30, at the St Julien Hotel and Spa in Boulder, CO.

1 Oct 2009

Phase 1 clinical trial to test safety and activity of human MAB launched in India

MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.

1 Oct 2009

Intoxicated trauma patients have higher survial rates than sober patients: Study

Trauma patients who were intoxicated before their injuries were more likely to survive than trauma patients who suffered similar injuries but were sober at the time, according to a study published in the October edition of the American Surgeon that was conducted by researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed).

1 Oct 2009

Novartis Oncology, Amgen, GlaxoSmithKline and Veridex honored with 2009 Prix Galien Award

The Prix Galien USA committee celebrated members of the science and biotechnology industries last night for the development and discovery of drugs and technologies that improve the human condition.

1 Oct 2009

Researchers stress the importance of ensuring quality psychiatric treatment in general practice settings

Fifty-nine percent of all prescriptions filled for psychotropic medications are written by general practitioners, according to a research report published this month in Psychiatric Services.

1 Oct 2009

Retailers join to support breast cancer research

This October, retailers nationwide are joining the fight against breast cancer by offering pink ribbon products that benefit research, treatment and education programs at City of Hope, one of the nation’s leading cancer research and treatment centers. From skin and hair care treatments to apparel to office products, consumers can feel good about their purchases and help support lifesaving cancer research.

1 Oct 2009

Membrane-bound Fas ligand is essential for cell death: Researchers

Walter and Eliza Hall Institute researchers have put an end to a 10-year debate over which form of a molecular messenger called Fas ligand is responsible for killing cells during programmed cell death (also called apoptosis).

1 Oct 2009

NIH awards $10.5 million grant for OCD treatment research

A new research center exploring the science underlying a potential new treatment for obsessive-compulsive disorder has been established at the University of Rochester Medical Center, thanks to a $10.5 million award from the National Institute of Mental Health.

1 Oct 2009

Effect of healthcare reform on treating cardiovascular disease patients

The Ninth Annual Controversies and Advances in Treatment of Cardiovascular Disease continuing medical education conference will feature several discussions and presentations on how healthcare reform could affect cardiovascular disease patients' diagnosis, treatment and outcome.

1 Oct 2009

Research News and Research

Merrimack and sanofi-aventis collaborate to develop and co-commercialize MM-121, a monoclonal antibody

Study aims to discover effective antibiotics to fight against hard-to-treat microbes

NAACP endorses optometric vision therapy at its 100th Anniversary Convention

Public lecture to highlight what causes cell division to go wrong and lead to cancer

Studies show vitamin D plays an important role in preventing respiratory infections

Cutting Edge Information hopes to see ill patients have speedier access to potential cures

Raptor Pharmaceutical appoints Llew Keltner to its board of directors

CCF to continue its million dollar ad campaign against NYC's PSA campaign

Cord Blood America to open cryogenic research and storage laboratory in Las Vegas

Children and adolescents over five are at risk from malaria

Stem cell therapy aims to prevent permanent damage from heart attacks

Tata Interactive Systems collaborates with Bersin & Associates for TLF 2009

Phase 1 clinical trial to test safety and activity of human MAB launched in India

Intoxicated trauma patients have higher survial rates than sober patients: Study

Novartis Oncology, Amgen, GlaxoSmithKline and Veridex honored with 2009 Prix Galien Award

Researchers stress the importance of ensuring quality psychiatric treatment in general practice settings

Retailers join to support breast cancer research

Membrane-bound Fas ligand is essential for cell death: Researchers

NIH awards $10.5 million grant for OCD treatment research

Effect of healthcare reform on treating cardiovascular disease patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News